EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.1.1.63 | Glioma |
31426864 |
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma. |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
| 2.1.1.63 | Neoplasms |
32330495 |
3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells. |
unassigned |
0 |
| 2.1.1.63 | Glioblastoma |
33827387 |
4-Acetylantrocamol LT3 Inhibits Glioblastoma Cell Growth and Downregulates DNA Repair Enzyme O6-Methylguanine-DNA Methyltransferase. |
ongoing research
unassigned |
1
0 |
| 2.1.1.63 | Glioma |
30081068 |
?-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. |
therapeutic application
unassigned |
2
0 |
| 2.1.1.63 | Glioblastoma |
32075134 |
A "Clickable" Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT. |
unassigned |
0 |
| 2.1.1.63 | Neoplasms |
29136645 |
A 4-miRNA signature to predict survival in glioblastomas. |
diagnostic usage
unassigned |
2
0 |
| 2.1.1.63 | Astrocytoma |
14570288 |
A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. |
ongoing research
therapeutic application
unassigned |
2
3
0 |
| 2.1.1.63 | Glioma |
14570288 |
A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. |
ongoing research
therapeutic application
unassigned |
2
3
0 |
| 2.1.1.63 | Neoplasms |
14570288 |
A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. |
ongoing research
therapeutic application
unassigned |
2
3
0 |
| 2.1.1.63 | Neoplasms |
25145500 |
A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
